Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback